山东大学耳鼻喉眼学报

• 论文 • 上一篇    下一篇

倍频532nm激光治疗糖尿病性黄斑水肿

于东珍, 赵梅   

  1. 聊城市第二人民医院眼科,山东 临清 252600
  • 收稿日期:2006-06-19 修回日期:1900-01-01 出版日期:2006-08-24 发布日期:2006-08-24
  • 通讯作者: 于东珍

IRIS532 overtone laser photocoagulation for diabetic macular edema

YU Dong-zhen, ZHAO Mei   

  1. Department of Ophthalmology, Second People′s Hospital of Liaocheng City, Linqing 252600, Shandong, China
  • Received:2006-06-19 Revised:1900-01-01 Online:2006-08-24 Published:2006-08-24
  • Contact: YU Dong-zhen

摘要: 目的:观察激光治疗糖尿病性黄斑水肿(DME)的疗效。方法:回顾性分析DME患者45例(76眼),其中局限水肿44眼,弥漫性水肿32眼。对局限水肿行微血管瘤或扩张的毛细血管直接光凝,弥漫水肿行C形格栅或环形格栅光凝。主要指标依靠视力、眼底荧光素血管造影。结果:局限水肿中视力提高10眼(22.72%),不变25眼(56.82%),下降9眼(20.45%);弥漫水肿中视力提高10眼(31.25%),不变19眼(59.38%),下降3眼(9.38%)。局限水肿中水肿消退12眼(27.27%),减轻23眼(52.27%),未退9眼(20.45%)。弥漫水肿中水肿消退6眼(18.75%),减轻14眼(43.75%),未退12眼(38.71%)。结论:IRIS倍频532?nm激光治疗DME有效,局限性黄斑水肿比弥漫性黄斑水肿效果好。

关键词: 糖尿病视网膜病变, 黄斑水肿, 激光凝固术

Abstract: To investigate the effect of IRIS532 overtone laser photocoagulation treatment for diabetic macular edema. Methods: A retrospective study on 45 patients (76 eyes) were analyzed. Of them, 44 eyes of localized edema were treated with direct photocoagulation and 32 eyes of diffuse edema were treated with grid photocoagulation. Vision and fundus fluorescein angiography were analyzed. Results: Among patients with localized edema, visual acuity was improved in 2 lines or more in 10 eyes (22.72%), not changed in 25 eyes(56.82%), and declined in 9 eyes(20.45%), and among patients with diffuse edema, these were respectively in 10 eyes (31.25%), 19 eyes(59.38%) and 3 eyes(9.38%). Among patients with localized edema, edema disappeared in 12 eyes(27.27%), alleviated in 23 eyes (52.27%) and did not changed in 9 eyes(20.45%), and among patients with diffuse edema, these were respectively in 6 eyes(18.75%), 14 eyes(43.75%) and 12 eyes (38.71%). Conclusion: IRIS overtone 532nm laser photocoagulation is more effective for localized edema than for diffuse edema.

Key words: Macular edema, Diabetic retinopathy, Laser coagulation

[1] 周学义,李一鸣,王美菊,张苑苑,张历浊. 25+微创玻璃体视网膜手术联合玻璃体腔注射雷珠单抗治疗增生型糖尿病视网膜病变的临床观察[J]. 山东大学耳鼻喉眼学报, 2017, 31(4): 87-89.
[2] 周玮琰,王洪亚,杜秀娟,董卫红. 甘糖酯对糖尿病大鼠视网膜病变中血管生成因子VEGF表达的影响[J]. 山东大学耳鼻喉眼学报, 2017, 31(2): 90-95.
[3] 靳琳,潘庆敏,胡磊. 玻璃体腔注射雷珠单抗治疗CSME及NCSME的临床观察[J]. 山东大学耳鼻喉眼学报, 2017, 31(2): 96-98.
[4] 严槟,尹小芳,叶祖科,卢彦,洪剑威. 玻璃体腔注射雷珠单抗联合GLP治疗BRVO-ME的临床观察[J]. 山东大学耳鼻喉眼学报, 2017, 31(1): 110-113.
[5] 韩克阳,王淑雅,焦芮,于贝贝综述, 赵博军审校. 视网膜静脉阻塞的发病机制及黄斑水肿的抗-VEGF治疗[J]. 山东大学耳鼻喉眼学报, 2017, 31(1): 123-126.
[6] 严晓腾,冯军,康欣乐. 玻璃体腔注射康柏西普治疗视网膜静脉阻塞继发黄斑水肿的临床观察[J]. 山东大学耳鼻喉眼学报, 2016, 30(4): 105-108.
[7] 邵娜,张晗. 糖尿病患者行白内障超声乳化术后视力及眼底的变化[J]. 山东大学耳鼻喉眼学报, 2016, 30(1): 83-87.
[8] 邢凯,亢泽峰. 玻璃体腔内注射康柏西普治疗视网膜分支静脉阻塞继发黄斑水肿的疗效分析[J]. 山东大学耳鼻喉眼学报, 2016, 30(1): 80-82.
[9] 李俊英. 瑞舒伐他汀联合非诺贝特对老年糖尿病视网膜病变患者血管内皮功能的影响[J]. 山东大学耳鼻喉眼学报, 2015, 29(5): 72-75.
[10] 刘志高, 颜世龙, 胡尊霞, 孙同鑫, 杨明, 王玉. 济南市农村白内障患者糖尿病及糖尿病视网膜眼底病变患病率调查分析[J]. 山东大学耳鼻喉眼学报, 2015, 29(1): 38-39.
[11] 严晓腾, 冯军, 康欣乐. 曲安奈德玻璃体腔注射联合格栅样光凝治疗囊样黄斑水肿[J]. 山东大学耳鼻喉眼学报, 2015, 29(1): 60-63.
[12] 马栋, 郭承伟. 络治法对STZ诱导的糖尿病大鼠视网膜血管消化铺片中VCAM-1表达的影响[J]. 山东大学耳鼻喉眼学报, 2015, 29(1): 64-68.
[13] 刘海洋, 李甦雁, 张正培, 范巍. 改良膜分割与双手膜清除技术在23G玻璃体手术治疗增殖性糖尿病视网膜病变中的对比[J]. 山东大学耳鼻喉眼学报, 2015, 29(1): 52-55.
[14] 孙洪义, 张晗. 2型糖尿病患者超声乳化白内障摘除并人工晶体植入手术后黄斑区光学相干断层扫描改变[J]. 山东大学耳鼻喉眼学报, 2014, 28(6): 72-76.
[15] 刘蓓1,朱忠桥1,杜善双1,王丽丽2,杨新光1. 前期激光及曲安奈德应用对增殖性糖尿病视网膜病变玻璃体切割手术的影响[J]. 山东大学耳鼻喉眼学报, 2013, 27(2): 66-68.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!